Cabergoline and cardiac valve disease Patient Reports February 12, 2012
Cabergoline Side Effects Report #5047095-2
Cabergoline side effect was reported by a Physician from GERMANY on June 23, 2006. Female patient, 47 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: arrhythmia
, breast enlargement, cardiac valve disease, fibrocystic breast disease, galactorrhoea, hyperprolactinaemia, restless legs syndrome. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #4934249-6
Cabergoline side effect was reported by a Physician from GERMANY on Feb 23, 2006. Female patient, 47 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: arrhythmia
, breast swelling, cardiac valve disease, galactorrhoea, hyperprolactinaemia, rebound effect. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #4975544-4
Cabergoline side effect was reported by a Physician from GERMANY on Mar 31, 2006. Female patient, 47 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: arrhythmia
, cardiac valve disease, galactorrhoea, hyperprolactinaemia, hypertrophy breast. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #6004852-3
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Dec 04, 2008. Female patient was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac aneurysm, cardiac valve disease, dyspnoea, mitral valve incompetence, ventricular tachycardia. Cabergoline dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, ATENOLOL, ACETAMINOPHEN W, CREON, DOMPERIDONE, ENALAPRIL MALEATE, FERROUS SULPHATE, FLUOXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4825201-X
Cabergoline side effect was reported by a Physician from SPAIN on Nov 03, 2005. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac valve disease, cardiomegaly, dilatation atrial, mitral valve incompetence. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4934700-1
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2006. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cardiac murmur, cardiac valve disease, cardiomegaly, dilatation atrial, gallop rhythm present, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D). Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4714863-3
Cabergoline side effect was reported by a Physician from SPAIN on July 05, 2005. Male patient, 72 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac valve disease, soft tissue disorder. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4661108-9
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Male patient, 79 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: 0.5 MG (DAILY), ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, MADOPAR, SELEGILINE. Patient recovered.Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.Cabergoline Side Effects Report #4700600-5
Cabergoline side effect was reported by a Physician from on June 15, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with PERMAX, LEVODOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4710546-4
Cabergoline side effect was reported by a Physician from JAPAN on June 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with PERMAX, LEVODOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4753590-3
Cabergoline side effect was reported by a Physician from ITALY on Aug 13, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, CLONAZEPAM, REMERON. Patient recovered.Cabergoline Side Effects Report #5304905-9
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on Apr 11, 2007. Male patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac failure, cardiac valve disease, constipation
, dyspnoea paroxysmal nocturnal, haemodynamic instability, ileus, megacolon, neuroleptic malignant syndrome. Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4629438-4
Cabergoline side effect was reported by a Physician from on Mar 24, 2005. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aortic valve incompetence, cardiac failure, cardiac valve disease, cardiomegaly, condition aggravated, echocardiogram abnormal, mitral valve incompetence, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4844972-X
Cabergoline side effect was reported by a Physician from SWEDEN on Nov 18, 2005. Male patient, 67 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial septal defect, cardiac valve disease, musculoskeletal stiffness, osteitis, pleurisy, prostate cancer
, right ventricular failure, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPARK, REMERON, SINEMET, LEVODOPA, ELDEPRYL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5150896-3
Cabergoline side effect was reported by a Physician from JAPAN on Oct 26, 2006. Female patient, 63 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve calcification, aortic valve incompetence, blood pressure increased, cardiac murmur, cardiac valve disease, electrocardiogram st segment abnormal, mitral valve disease, tricuspid valve disease. Cabergoline dosage: 4 MG (1 D),ORAL. Patient recovered.Cabergoline Side Effects Report #4896417-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Jan 17, 2006. Female patient, 62 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, EVERY DAY), ORAL. During the same period patient was treated with FUROSEMIDE, PERINDOPRIL, SPIRONOLACTONE, SALMETEROL, SALBUTAMOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5154439-X
Cabergoline side effect was reported by a Physician from GERMANY on Nov 02, 2006. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 12 MG, ORAL. During the same period patient was treated with COMTESS, SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5606744-8
Cabergoline side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 23, 2008. Female patient, 60 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: TEXT:4MG-FREQ:DAILY. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #4874864-1
Cabergoline side effect was reported by a Physician from JAPAN on Dec 22, 2005. Male patient, 60 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, refusal of treatment by patient. Cabergoline dosage: 4 MG (4 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5022439-6
Cabergoline side effect was reported by a Physician from JAPAN on May 22, 2006. Male patient, 60 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, refusal of treatment by patient. Cabergoline dosage: 4 MG (4 MG, QD), ORAL. Patient died.Cabergoline Side Effects Report #4704600-0
Cabergoline side effect was reported by a Physician from on June 17, 2005. Female patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5161996-6
Cabergoline side effect was reported by a Physician from SPAIN on Nov 07, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #4931009-7
Cabergoline side effect was reported by a Physician from SPAIN on Feb 14, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
, ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #5228273-6
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228286-4
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, heart valve insufficiency. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228299-2
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228332-8
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228339-0
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5228342-0
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5356927-X
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient, weighting 101.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac valve disease, constipation
, dyspnoea paroxysmal nocturnal, haemodynamic instability, ileus, megacolon, parkinson's disease
, pyrexia. Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE, MADOPAR, SEROQUEL, THYRADIN S, GASTER, LENDORMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5584636-0
Cabergoline side effect was reported by a Physician from JAPAN on Dec 27, 2007. Female patient, weighting 81.57 lb, was diagnosed with parkinson's disease
, insomnia, constipation
, gastritis, neurosis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, interstitial lung disease. Cabergoline dosage: unknown. During the same period patient was treated with MENESIT, SYMMETREL, AMOBAN, MAGNESIUM OXIDE, MARZULENE S, DEPAS. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4745694-6
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5027090-X
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on May 26, 2006. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #4966081-1
Cabergoline side effect was reported by a Physician from GERMANY on Mar 23, 2006. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #4968257-6
Cabergoline side effect was reported by a Physician from GERMANY on Mar 23, 2006. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #4984399-3
Cabergoline side effect was reported by a Physician from GERMANY on Apr 07, 2006. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5509357-1
Cabergoline side effect was reported by a Pharmacist from JAPAN on Oct 26, 2007. Male patient, 48 years of age, was diagnosed with depression
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, congestive cardiomyopathy, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with RIVOTRIL, LITHIUM CARBONATE, EPADEL, TRYPTANOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5532464-4
Cabergoline side effect was reported by a Physician from JAPAN on Nov 22, 2007. Male patient, weighting 176.4 lb, was diagnosed with depression
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, congestive cardiomyopathy, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, TRYPTANOL, RIVOTRIL, EPADEL, ALOSITOL, ROHYPNOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5218471-X
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, arrhythmia
, cardiac valve disease, chest pain
, dyspnoea, mitral valve incompetence, oedema, syncope, tricuspid valve incompetence. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5218475-7
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5218572-6
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5218578-7
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5218585-4
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5083046-2
Cabergoline side effect was reported by a Physician from GERMANY on Aug 02, 2006. Male patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.
Cabergoline and cardiac valve disease 